Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01030458Phase 4Completed
Phase 4, randomised, open-label trial of amlodipine and valsartan in hypertension (HTN) (2 arms), sponsored by KU Leuven. Primary endpoint: Sitting Systolic Blood Pressure on Automated Measurement at 6 months. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01030458.